The purpose of this review is to discuss the management strategies in patients with chronic lung disease such as chronic obstructive pulmonary disease, asthma, pleural diseases, and obstructive sleep apnea during the COVID-19 pandemic, with current literatures and international guidelines.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Over the past few months, coronavirus disease 2019 (COVID-19) has assumed the character of a pandemic, leading to significant global mortality mostly because of COVID-19–related pneumonia.
📊
Key Findings & Data:Pneumonia is likely to progress more severely in patients with underlying chronic lung disease.
💡
Conclusion & Impact:The purpose of this review is to discuss the management strategies in patients with chronic lung disease such as chronic obstructive pulmonary disease, asthma, pleural diseases, and obstructive sleep apnea during the COVID-19 pandemic, with current literatures and international guidelines.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Özet
Over the past few months, coronavirus disease 2019 (COVID-19) has assumed the character of a pandemic, leading to significant global mortality mostly because of COVID-19–related pneumonia. Pneumonia is likely to progress more severely in patients with underlying chronic lung disease. The purpose of this review is to discuss the management strategies in patients with chronic lung disease such as chronic obstructive pulmonary disease, asthma, pleural diseases, and obstructive sleep apnea during the COVID-19 pandemic, with current literatures and international guidelines.
🔖
Cite This Article
EDİS, E. Ç. (2020). Chronic Pulmonary Diseases and COVID-19. Turkish Thoracic Journal, Cilt: 21 - Sayı: 5, 345–349. https://ajindex.com/articles/417960
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with communityacquired pneumonia. Eur Respir J 2006; 28: 346-51. [Crossref] 2. Lippi G, Henry BM. Chronic Obstructive Pulmonary Disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med 2020;doi: 10.1016/j.rmed.2020.105941. [Crossref] 3. Guan WJ, Ni Z, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;doi: 10.1056/ NEJMoa2002032 [Crossref] 4. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalance of underlying diease in hospitalized patients with COVID-19: A systematic review and meta-analysis. Arch Acad Emerg Med 202; 8: e35. 5. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 2020;12:6049-57. [Crossref] 6. Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis. J Med Virol 2020; 15;10.1002/jmv.25889. [Crossref] 7. Leung JM, Yang CX, Tam A, et al. ACE-2 Expression in the small airway epithelia and smokers and COPD patients: Implications for COVID-19. Eur Respir J 2020; pii.2000688. doi: 10.1183/13993003.00688-2020. [Crossref] 8. Global Initiative for Chronic Obstructive Lung Disease. Access date: 23 April 2020. Available from: https://goldcopd.org/goldcovid19-guidance/ 9. COVID-19 rapid guideline: community- based care of patients with chronic obstructive pulmonary disease (COPD). NICE guideline. Published: 9 April 2020 Available from: www.nice. org.uk/guidance/ng168 10. Bhutani M, Hernandez P, Bourbeau J et al. Addressing therapeutic questions to help Canadian health care professionals optimize COPD management for their patients during the COVID-19 pandemic. Canadian Journal of Respiratory Critiacal Care and Sleep Medicine. In press. Version 1.0 submitted for publication in the CJRCCSM on April 8, 2020. Access date: 23 April 2020. Available from: https://cts-sct.ca/covid-19/covid19-copd/ 11. Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 (confirmed or suspected) 6.4.2020, Ver 3. Access date: 23 April 2020. Available from: https: //www.england.nhs.uk/coronavirus/wp-content/uploads/ sites/52/2020/03/specialty-guide-NIV-respiratory-support-andcoronavirus-v3.pdf 12. Celebioglu E. Asthma and COVID-19. Asthma Allergy Immunol 2020;18:56-7. [Crossref] 13. Zhang IJ, Dong X,